InfuSystem (INFU) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $13.92, +2.35% vs the prior close of $13.60.
- Volume 88.40K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
INFU rises 2.4% to $13.92, a 52-week high. Closed at $13.92, +2.35% vs the prior close of $13.60. Day range $13.69–$14.02, opened at $13.72.
INFU daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — INFU rises 2.4% to $13.92, a 52-week high
- Closed at $13.92, +2.35% vs the prior close of $13.60. Day range $13.69–$14.02, opened at $13.72.
- Volume was 88.40K shares, 0.7x its 50-day average of 130.27K.
- Price is +10.7% vs its 50-day average ($12.58) and +38.7% vs its 200-day average ($10.04).
- 52-week range $7.29–$14.02; today's close sits at 99% of that range, 0.7% below the 52-week high.
Oct 14, 2026 — INFU rises 0.8% to $13.60
- Closed at $13.60, +0.82% vs the prior close of $13.49. Day range $13.34–$13.80, opened at $13.42.
- Volume was 142.10K shares, 1.0x its 50-day average of 139.06K.
- Price is +8.4% vs its 50-day average ($12.54) and +35.8% vs its 200-day average ($10.01).
- 52-week range $7.29–$13.85; today's close sits at 96% of that range, 1.8% below the 52-week high.
Oct 13, 2026 — INFU dips 0.8% to $13.49
- Closed at $13.49, -0.81% vs the prior close of $13.60. Day range $13.47–$13.80, opened at $13.63.
- Volume was 103.10K shares, 0.7x its 50-day average of 141.76K.
- Price is +7.8% vs its 50-day average ($12.52) and +35.0% vs its 200-day average ($9.99).
- 52-week range $7.29–$13.85; today's close sits at 95% of that range, 2.6% below the 52-week high.
Oct 12, 2026 — INFU ends flat (+0.3%) to $13.60, a 52-week high, 4 up days in a row
- Closed at $13.60, +0.29% vs the prior close of $13.56. Day range $13.51–$13.82, opened at $13.60.
- Volume was 116.30K shares, 0.8x its 50-day average of 142.89K.
- Price is +9.4% vs its 50-day average ($12.43) and +36.4% vs its 200-day average ($9.97).
- 52-week range $7.29–$13.85; today's close sits at 96% of that range, 1.8% below the 52-week high.
- That makes 4 straight gains.
Oct 9, 2026 — INFU rises 1.1% to $13.56, a 52-week high, 3 up days in a row
- Closed at $13.56, +1.12% vs the prior close of $13.41. Day range $13.41–$13.65, opened at $13.45.
- Volume was 63.30K shares, 0.4x its 50-day average of 144.65K — lighter than usual.
- Price is +9.9% vs its 50-day average ($12.34) and +36.3% vs its 200-day average ($9.95).
- 52-week range $7.29–$13.85; today's close sits at 96% of that range, 2.1% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — INFU rises 0.6% to $13.41
- Closed at $13.41, +0.60% vs the prior close of $13.33. Day range $13.09–$13.50, opened at $13.25.
- Volume was 94.70K shares, 0.6x its 50-day average of 146.22K.
- Price is +9.4% vs its 50-day average ($12.26) and +35.1% vs its 200-day average ($9.92).
- 52-week range $7.29–$13.85; today's close sits at 93% of that range, 3.2% below the 52-week high.
Oct 7, 2026 — INFU rises 0.5% to $13.33
- Closed at $13.33, +0.45% vs the prior close of $13.27. Day range $13.19–$13.65, opened at $13.19.
- Volume was 113.80K shares, 0.8x its 50-day average of 146.22K.
- Price is +9.4% vs its 50-day average ($12.18) and +34.6% vs its 200-day average ($9.90).
- 52-week range $7.29–$13.85; today's close sits at 92% of that range, 3.8% below the 52-week high.
Oct 6, 2026 — INFU dips 1.6% to $13.27
- Closed at $13.27, -1.63% vs the prior close of $13.49. Day range $13.21–$13.75, opened at $13.51.
- Volume was 76.70K shares, 0.5x its 50-day average of 147.27K — lighter than usual.
- Price is +9.5% vs its 50-day average ($12.11) and +34.3% vs its 200-day average ($9.88).
- 52-week range $7.29–$13.85; today's close sits at 91% of that range, 4.2% below the 52-week high.
Oct 5, 2026 — INFU rises 2.5% to $13.49, a 52-week high
- Closed at $13.49, +2.51% vs the prior close of $13.16. Day range $13.15–$13.85, opened at $13.23.
- Volume was 137.70K shares, 0.9x its 50-day average of 146.48K.
- Price is +12.1% vs its 50-day average ($12.04) and +36.8% vs its 200-day average ($9.86).
- 52-week range $7.29–$13.85; today's close sits at 95% of that range, 2.6% below the 52-week high.
Oct 2, 2026 — INFU rises 2.7% to $13.16, a 52-week high
- Closed at $13.16, +2.65% vs the prior close of $12.82. Day range $12.91–$13.20, opened at $12.99.
- Volume was 124.10K shares, 0.8x its 50-day average of 146.01K.
- Price is +10.1% vs its 50-day average ($11.95) and +33.7% vs its 200-day average ($9.84).
- 52-week range $7.29–$13.20; today's close sits at 99% of that range, 0.3% below the 52-week high.
INFU latest news & SEC filings
Every SEC filing by or about INFU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Funke Jerod converted options/RSUs into 7,157 shares on Oct 9, 2026; now holds 36,811
- Funke Jerod had withheld for taxes 2,101 shares at $13.56 (≈$28.49K) on Oct 9, 2026; now holds 34,710
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $36.93M (prior year $36.00M) (+2.6% vs Jun 30, 2025)
- Net income: $3.23M (prior year $2.60M) (+24.3% vs Jun 30, 2025)
- Diluted EPS: $0.15 (prior year $0.12) (+25.0% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade INFU
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 24, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.32% (largest 3.1%).
- Liquidity: about 132.88K shares (≈$1.85M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $13.92 vs a range of $7.29–$14.02 (99% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 0 sales; latest: Carrie Lachance bought 1,000 shares on May 11, 2026.
- Latest filings: 8-K Sep 17, 2026; 10-Q Aug 4, 2026; 8-K Aug 4, 2026.
- Share count: 19.92M shares outstanding (Jul 31, 2026), -2.5% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
INFU market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 13.72 | 14.02 | 13.69 | 13.92 | 88.40K |
| Oct 14, 2026 | 13.42 | 13.80 | 13.34 | 13.60 | 142.10K |
| Oct 13, 2026 | 13.63 | 13.80 | 13.47 | 13.49 | 103.10K |
| Oct 12, 2026 | 13.60 | 13.82 | 13.51 | 13.60 | 116.30K |
| Oct 9, 2026 | 13.45 | 13.65 | 13.41 | 13.56 | 63.30K |
| Oct 8, 2026 | 13.25 | 13.50 | 13.09 | 13.41 | 94.70K |
| Oct 7, 2026 | 13.19 | 13.65 | 13.19 | 13.33 | 113.80K |
| Oct 6, 2026 | 13.51 | 13.75 | 13.21 | 13.27 | 76.70K |
| Oct 5, 2026 | 13.23 | 13.85 | 13.15 | 13.49 | 137.70K |
| Oct 2, 2026 | 12.99 | 13.20 | 12.91 | 13.16 | 124.10K |
| Oct 1, 2026 | 12.78 | 13.06 | 12.62 | 12.82 | 111.80K |
| Sep 30, 2026 | 13.02 | 13.08 | 12.76 | 12.89 | 101.60K |
| Sep 29, 2026 | 12.82 | 13.05 | 12.65 | 13.03 | 85.30K |
| Sep 28, 2026 | 12.69 | 12.89 | 12.59 | 12.87 | 108.40K |
| Sep 25, 2026 | 12.69 | 12.80 | 12.47 | 12.71 | 106.60K |
| Sep 24, 2026 | 12.75 | 12.86 | 12.50 | 12.69 | 109.10K |
| Sep 23, 2026 | 13.00 | 13.03 | 12.63 | 12.70 | 151.20K |
| Sep 22, 2026 | 12.95 | 13.20 | 12.87 | 13.11 | 164.10K |
| Sep 21, 2026 | 12.85 | 12.94 | 12.66 | 12.80 | 153.00K |
| Sep 18, 2026 | 12.43 | 13.15 | 12.25 | 12.85 | 506.20K |
About InfuSystem
InfuSystem (INFU) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ROCHESTER HILLS, MI. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1337013.
INFU board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kenneth D. Eichenbaum | Director | May 14, 2026 |
| Paul Andrew Gendron | Director | May 14, 2026 |
| Beverly A Huss | Director | May 14, 2026 |
| Ronald T Hundzinski | Director | May 14, 2026 |
| Carrie Lachance | President and CEO | May 19, 2026 |
| John J Sviokla | Director | May 14, 2026 |
| Scott Shuda | Director | Sep 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Addam Chupa | Executive VP and CIO | May 19, 2026 |
| Jerod Funke | EVP-Chief HR Officer | May 19, 2026 |
| Carrie Lachance | President and CEO | May 19, 2026 |
| Barry G Steele | Executive VP and CFO | May 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 11, 2026 | Carrie Lachance | Buy | 1,000 | $8.46 |
| May 8, 2026 | Carrie Lachance | Buy | 2,000 | $8.83 |
| May 8, 2026 | Paul Andrew Gendron | Buy | 5,000 | $8.88 |
| May 8, 2026 | Barry G Steele | Buy | 7,000 | $8.71 |
| Mar 2, 2026 | Barry G Steele | Buy | 2,064 | $9.16 |
INFU financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $143.44M | $6.63M | 0.31 | $24.41M |
| Dec 31, 2024 | $134.86M | $2.35M | 0.11 | $20.46M |
| Dec 31, 2023 | $125.78M | $872.00K | 0.04 | $11.22M |
| Dec 31, 2022 | $109.91M | $18.00K | 0.00 | $17.52M |
| Dec 31, 2021 | $102.38M | $1.42M | 0.06 | $18.32M |
Latest balance sheet: total assets $97.70M, total liabilities $38.55M, cash $964.00K (as of Jun 30, 2026).
INFU earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $12.32 |
| May 7, 2026 | 8-K Item 2.02 (results) | $8.97 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $8.60 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $9.46 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $6.07 |
| May 8, 2025 | 8-K Item 2.02 (results) | $5.47 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $6.47 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.34 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on INFU
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.